Skip to content
中文产业新闻精选评分75Chinese source

FDA加速批准首个CELMoD药物iberdomide联合方案治疗多发性骨髓瘤

【FDA资讯】MM迎来首个CELMoD药物——iberdomide联合治疗显著提升MRD阴性CR率

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.